Demystifying palliative and hospice care
Armed with answers, you can provide patients and families with the information they need to make care decisions. Takeaways: Patients and their families may…
Oncology
FDA clears stereotactic radiotherapy system for treating breast cancer
On Dec. 22, the U.S. Food and Drug Administration (FDA) cleared the GammaPod system, a new noninvasive stereotactic radiotherapy system for treating breast cancer.…
FDA approves first biosimilar for certain breast, stomach cancers
On Dec. 1, the U.S. Food and Drug Administration (FDA) approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients…
Hazardous drugs, a safety blind spot
Know the risks of handling many commonly administered drugs. WARFARIN, OXYTOCIN, CLONAZEPAM—registered nurses administer millions of these drugs daily with little awareness that they…
Genetics in the clinical setting
This article explains basic genetic terminology and processes and describes assessment steps to help clinical nurses care for and manage patients at risk for…
FDA approves new breast cancer treatment
On Sept. 28, the U.S. Food and Drug Administration (FDA) approved Verzenio (abemaciclib) to treat adult patients who have hormone receptor (HR)-positive, human epidermal…
Finding meaning after a patient’s death
A common source of stress for nurses in oncology is the death of a patient they’ve cared for over a long time. Relationships develop…
Ostomy management: Nuts and bolts for every nurse’s toolbox
Learn the facts about ostomy care. By Mary H. Zeigler, MS, CRRN, CWON, and Allison Min, BSN, CRRN An Ostomy is a surgically created…
FDA approves first biosimilar for treatment of cancer
On Sept. 14, the U.S. Food and Drug Administration (FDA) approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment of multiple…
Addressing the opioid epidemic
Funding and access to care are crucial to solving substance use disorders. The word crisis can be defined in several ways. But when looking…
Recognizing complications in the oncology patient
Quick response includes paying attention to the details. Takeaways: Rapid assessment is key to identifying early complications in the oncology patient. Sense of urgency…
FDA clears patient-assisted mammography system
On Sept. 1, the U.S. Food and Drug Administration (FDA) cleared the first 2D digital mammography system that allows patients to increase or decrease…
Demystifying palliative and hospice care
Armed with answers, you can provide patients and families with the information they need to make care decisions. Takeaways: Patients and their…
FDA clears stereotactic radiotherapy system for treating breast cancer
On Dec. 22, the U.S. Food and Drug Administration (FDA) cleared the GammaPod system, a new noninvasive stereotactic radiotherapy system for treating…
FDA approves first biosimilar for certain breast, stomach cancers
On Dec. 1, the U.S. Food and Drug Administration (FDA) approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment…
Hazardous drugs, a safety blind spot
Know the risks of handling many commonly administered drugs. WARFARIN, OXYTOCIN, CLONAZEPAM—registered nurses administer millions of these drugs daily with little awareness…
Genetics in the clinical setting
This article explains basic genetic terminology and processes and describes assessment steps to help clinical nurses care for and manage patients at…
FDA approves new breast cancer treatment
On Sept. 28, the U.S. Food and Drug Administration (FDA) approved Verzenio (abemaciclib) to treat adult patients who have hormone receptor (HR)-positive,…
Finding meaning after a patient’s death
A common source of stress for nurses in oncology is the death of a patient they’ve cared for over a long time.…
Ostomy management: Nuts and bolts for every nurse’s toolbox
Learn the facts about ostomy care. By Mary H. Zeigler, MS, CRRN, CWON, and Allison Min, BSN, CRRN An Ostomy is a…
FDA approves first biosimilar for treatment of cancer
On Sept. 14, the U.S. Food and Drug Administration (FDA) approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment…
Addressing the opioid epidemic
Funding and access to care are crucial to solving substance use disorders. The word crisis can be defined in several ways. But…
Recognizing complications in the oncology patient
Quick response includes paying attention to the details. Takeaways: Rapid assessment is key to identifying early complications in the oncology patient. Sense…
FDA clears patient-assisted mammography system
On Sept. 1, the U.S. Food and Drug Administration (FDA) cleared the first 2D digital mammography system that allows patients to increase…
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.